Grown Rogue International (GRUSF) Long-Term Deferred Tax (2018 - 2026)
Grown Rogue International's (GRUSF) quarterly Long-Term Deferred Tax came in at $1.9 million in Q1 2026, up 539.97% year-on-year from $303778.0 in Q1 2025, and up 27.67% quarter-over-quarter from $1.5 million in Q4 2025.
Grown Rogue International (GRUSF) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends
Grown Rogue International's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- On a quarterly basis, Long-Term Deferred Tax rose 539.97% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 539.97% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 120.02% from the prior year.
- Long-Term Deferred Tax advanced to $1.9 million in Q1 2026 per GRUSF's latest filing, from $1.5 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $317.2 billion in Q3 2025 and bottomed at $180911.7 in Q4 2023.
- The 4-year median for Long-Term Deferred Tax is $470358.0 (2023), against an average of $28.8 billion.
- Biggest YoY gain for Long-Term Deferred Tax was 61809124.46% in 2025; the steepest drop was 10.53% in 2025.
- Year by year, Long-Term Deferred Tax stood at $180911.7 in 2023, then surged by 282.57% to $692105.0 in 2024, then soared by 120.02% to $1.5 million in 2025, then grew by 27.67% to $1.9 million in 2026.
- Per Business Quant, the three latest GRUSF Long-Term Deferred Tax figures stand at $1.9 million (Q1 2026), $1.5 million (Q4 2025), and $317.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 317.24 Bn |
| Jun 30, 2025 | 317,241.00 |
| Mar 31, 2025 | 303,778.00 |
| Dec 31, 2024 | 692,105.00 |
| Sep 30, 2024 | 513,258.34 |
| Jun 30, 2024 | 286,215.93 |
| Mar 31, 2024 | 339,545.00 |
| Dec 31, 2023 | 180,911.69 |
| Oct 31, 2023 | 470,358.00 |
| Oct 31, 2018 | 463,960.00 |
| Apr 30, 2018 | 76,504.00 |